Literature DB >> 6955994

HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).

A Cambon-de Mouzon, E Ohayon, G Hauptmann, A Sevin, M Abbal, E Sommer, H Vergnes, J Ducos.   

Abstract

The Basques were previously shown to present a high frequency of HLA-B18 and BfF1, which are known to be associated with insulin dependent diabetes mellitus (IDDM). During the VIII International Histocompatibility Workshop, we studied HLA-A, B, C, DR; Bf, C4 and GLO.I polymorphisms in 51 unrelated French Basque IDDM patients and in 50 controls. Haplotypes were established by family studies in all controls and some patients. Two haplotypes were frequently found in the controls: HLA-A1, Bw57, BfS, C4 F1S, DR7 and HLA-Aw30, Cw5, B18, Bf F1, C4Fs degree, DR3. The first one was not found in the patients. All the components of the second haplotype had increased frequencies possibly as a consequence of linkage disequilibrium with HLA-DR3: a highly significant association between IDDM and HLA-DR3 was observed (90.2% vs 24.0%, relative risk (RR) = 29.1, P less than 10(-11)). The HLA-DR4 frequency was slightly increased (37.3% vs 16.0%), and HLA-DR2 was not found. The silent allele C4s degree was particularly associated with early diagnosed IDDM (86.7% in patients with age at onset under 20 years vs 57.1% in other patients, P less than 0.02). The high relative risk for HLA-DR3/DR4 heterozygous vs that of individuals, possibly HLA-DR3 homozygous, supported the hypothesis that two HLA-DR linked genetic factors could be involved in the inheritance of IDDM susceptibility.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6955994     DOI: 10.1111/j.1399-0039.1982.tb01463.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  19 in total

1.  Genetic structure of the novel low-frequency haplotype HLA-B49, SC01, DR4 and its contribution to insulin-dependent diabetes susceptibility.

Authors:  O G Segurado; P Iglesias-Casarrubios; P Morales; J Martínez-Laso; J Partanen; R D Campbell; A Arnaiz-Villena
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Two distinct HLA-DR3 haplotypes are associated with age related heterogeneity in type 1 (insulin-dependent) diabetes.

Authors:  I Deschamps; A Marcelli-Barge; J C Poirier; O Cohen-Haguenauer; H Abderrahim; D Cohen; H Lestradet; J Hors
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 3.  The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

4.  The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication?

Authors:  L Contu; C Carcassi; J Dausset
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Order of class III genes relative to HLA genes determined by the haplotype method.

Authors:  A N Wilton; B Charlton
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Fennessy; K Metcalfe; G A Hitman; M Niven; P A Biro; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

7.  Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population.

Authors:  J L Vicario; J Martinez-Laso; A Corell; J M Martin-Villa; P Morales; G Lledo; O G Segurado; D de Juan; A Arnaiz-Villena
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

8.  Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.

Authors:  P Ruuska; J Ilonen; A Mustonen; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

9.  Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA.

Authors:  I Santin; A Castellanos-Rubio; A M Aransay; G Gutierrez; S Gaztambide; I Rica; J L Vicario; J A Noble; L Castaño; J R Bilbao
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

10.  Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.

Authors:  H Kelly; V J McCann; P H Kay; R L Dawkins
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.